Mariner Investment Group’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Mariner Investment Group’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,000	Closed	-$99K	–	166
2022 Q3	$99K	Hold	10,000	–	–	0.11%	164
2022 Q2	$98K	Hold	10,000	–	–	0.1%	173
2022 Q1	$98K	Hold	10,000	–	–	0.12%	150
2021 Q4	$97K	Hold	10,000	–	–	0.04%	164
2021 Q3	$98K	Buy	+10,000	New	+$96.3K	0.27%	95

Other funds holding MSAC

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

MSU

Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Mariner Investment Group's MSAC Position: Q4 2022 in Review

Mariner Investment Group sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q4 2022, closing a stake of 10,000 shares — an estimated $99K sold.

Mariner Investment Group first reported a position in MSAC in Q3 2021 and held it in 5 quarters. The position peaked at $99K in Q3 2022. 49 funds tracked by Wall St. Rank hold MSAC as of Q4 2022.

Mariner Investment Group reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q4 2022 after selling out during the quarter.
Mariner Investment Group sold 10,000 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q4 2022, an estimated $99K.
Mariner Investment Group first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q3 2021 and held it in 5 quarters.
Mariner Investment Group's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $99K in Q3 2022.
49 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q4 2022.

Based on Mariner Investment Group's 13F filing for Q4 2022, filed 14 Feb 2023.